Willingdon Wealth Management’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q1 | $581K | Sell |
10,429
-337
| -3% | -$18.8K | 0.15% | 85 |
|
|
2019
Q4 | $691K | Sell |
10,766
-1,164
| -10% | -$74.7K | 0.14% | 98 |
|
|
2019
Q3 | $605K | Buy |
11,930
+36
| +0.3% | +$1.83K | 0.13% | 99 |
|
|
2019
Q2 | $539K | Sell |
11,894
-2,050
| -15% | -$92.9K | 0.13% | 102 |
|
|
2019
Q1 | $665K | Sell |
13,944
-78,332
| -85% | -$3.74M | 0.16% | 106 |
|
|
2018
Q4 | $4.8M | Sell |
92,276
-925
| -1% | -$48.1K | 1.38% | 14 |
|
|
2018
Q3 | $5.79M | Buy |
93,201
+3,674
| +4% | +$228K | 1.58% | 12 |
|
|
2018
Q2 | $4.95M | Buy |
89,527
+3,977
| +5% | +$220K | 1.52% | 14 |
|
|
2018
Q1 | $5.41M | Buy |
85,550
+15,182
| +22% | +$960K | 1.71% | 9 |
|
|
2017
Q4 | $4.31M | Buy |
70,368
+4,075
| +6% | +$250K | 1.42% | 15 |
|
|
2017
Q3 | $4.23M | Buy |
66,293
+777
| +1% | +$49.5K | 1.54% | 17 |
|
|
2017
Q2 | $3.65M | Sell |
65,516
-56,102
| -46% | -$3.13M | 1.45% | 14 |
|
|
2017
Q1 | $6.61M | Buy |
121,618
+55,420
| +84% | +$3.01M | 2.68% | 5 |
|
|
2016
Q4 | $3.87M | Sell |
66,198
-1,966
| -3% | -$115K | 1.83% | 13 |
|
|
2016
Q3 | $3.68M | Buy |
68,164
+17,063
| +33% | +$920K | 1.86% | 9 |
|
|
2016
Q2 | $3.76M | Sell |
51,101
-26,564
| -34% | -$1.95M | 1.93% | 7 |
|
|
2016
Q1 | $4.96M | Buy |
77,665
+48,701
| +168% | +$3.11M | 3.04% | 2 |
|
|
2015
Q4 | $1.99M | Buy |
28,964
+20,264
| +233% | +$1.39M | 1.82% | 14 |
|
|
2015
Q3 | $515K | Buy |
+8,700
| New | +$515K | 0.61% | 59 |
|